AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:23 am Purchase | 2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | AVORO CAPITAL ADVISORS LLC | 13,411,111 9.900% | 2,786,111 (+26.22%) | Filing |
| 2023-02-14 09:36 am Purchase | 2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | AVORO CAPITAL ADVISORS LLC | 10,625,000 9.600% | 2,069,445 (+24.19%) | Filing |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | AVORO CAPITAL ADVISORS LLC | 8,555,555 8.900% | 8,555,555 (New Position) | Filing |